Patricia L. Mitchell

2.5k total citations
62 papers, 1.5k citations indexed

About

Patricia L. Mitchell is a scholar working on Epidemiology, Molecular Biology and Physiology. According to data from OpenAlex, Patricia L. Mitchell has authored 62 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 16 papers in Molecular Biology and 14 papers in Physiology. Recurrent topics in Patricia L. Mitchell's work include Liver Disease Diagnosis and Treatment (12 papers), Fatty Acid Research and Health (10 papers) and Genetic Associations and Epidemiology (7 papers). Patricia L. Mitchell is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Fatty Acid Research and Health (10 papers) and Genetic Associations and Epidemiology (7 papers). Patricia L. Mitchell collaborates with scholars based in Canada, United States and Estonia. Patricia L. Mitchell's co-authors include Roger S. McLeod, André Marette, D Currie, Pedro J. Beltran, Brian Belmontes, Gordon Moody, Robert Radinsky, Elaina Cajulis, Yong Suk Chung and Frank J. Calzone and has published in prestigious journals such as The Lancet, Circulation and Nature Medicine.

In The Last Decade

Patricia L. Mitchell

58 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patricia L. Mitchell Canada 21 486 430 296 256 235 62 1.5k
Dennis D. Black United States 24 523 1.1× 382 0.9× 293 1.0× 203 0.8× 328 1.4× 80 2.4k
Martina Müller‐Nurasyid Germany 21 538 1.1× 315 0.7× 152 0.5× 114 0.4× 194 0.8× 56 1.8k
Ivan Tancevski Austria 25 434 0.9× 229 0.5× 169 0.6× 92 0.4× 205 0.9× 81 1.9k
Edgar Delvin Canada 25 288 0.6× 382 0.9× 311 1.1× 105 0.4× 255 1.1× 64 2.0k
Heather Teague United States 22 364 0.7× 336 0.8× 214 0.7× 79 0.3× 255 1.1× 57 1.7k
Jean‐Louis Paul France 26 758 1.6× 201 0.5× 227 0.8× 111 0.4× 400 1.7× 75 2.1k
Kiyonori Kuriki Japan 25 667 1.4× 527 1.2× 283 1.0× 322 1.3× 121 0.5× 67 1.8k
Hennie M.J. Roelofs Netherlands 27 947 1.9× 269 0.6× 118 0.4× 330 1.3× 173 0.7× 83 2.2k
Yoshikazu Ohtsuka Japan 26 456 0.9× 399 0.9× 164 0.6× 117 0.5× 176 0.7× 116 1.9k
James P. Nolan United States 25 395 0.8× 248 0.6× 291 1.0× 357 1.4× 537 2.3× 59 2.4k

Countries citing papers authored by Patricia L. Mitchell

Since Specialization
Citations

This map shows the geographic impact of Patricia L. Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia L. Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia L. Mitchell more than expected).

Fields of papers citing papers by Patricia L. Mitchell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia L. Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia L. Mitchell. The network helps show where Patricia L. Mitchell may publish in the future.

Co-authorship network of co-authors of Patricia L. Mitchell

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia L. Mitchell. A scholar is included among the top collaborators of Patricia L. Mitchell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia L. Mitchell. Patricia L. Mitchell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gagnon, Éloi, Dipender Gill, Jérôme Bourgault, et al.. (2025). RNA interference versus antibody-based PCSK9 inhibition for the prevention of cardiovascular disease: a drug-target Mendelian randomization study. Cardiovascular Research. 121(7). 1066–1075.
2.
Bourgault, Jérôme, Marie‐Frédérique Gauthier, Simon Marceau, et al.. (2025). Associations between circulating amino acids and metabolic dysfunction‐associated steatotic liver disease in individuals living with severe obesity. Physiological Reports. 13(3). e70171–e70171.
3.
Gobeil, Émilie, Jérôme Bourgault, Patricia L. Mitchell, et al.. (2024). Genetic inhibition of angiopoietin-like protein-3, lipids, and cardiometabolic risk. European Heart Journal. 45(9). 707–721. 17 indexed citations
4.
Gagnon, Éloi, Émilie Gobeil, Jérôme Bourgault, et al.. (2023). Genetic control of body weight by the human brain proteome. iScience. 26(4). 106376–106376. 1 indexed citations
5.
Gagnon, Éloi, Patricia L. Mitchell, Hasanga D. Manikpurage, et al.. (2023). Impact of the gut microbiota and associated metabolites on cardiometabolic traits, chronic diseases and human longevity: a Mendelian randomization study. Journal of Translational Medicine. 21(1). 60–60. 48 indexed citations
6.
Gagnon, Éloi, Hasanga D. Manikpurage, Patricia L. Mitchell, et al.. (2023). Large-scale metabolomic profiling and incident non-alcoholic fatty liver disease. iScience. 26(7). 107127–107127. 8 indexed citations
7.
8.
Bourgault, Jérôme, Erik Abner, Hasanga D. Manikpurage, et al.. (2023). Proteome-Wide Mendelian Randomization Identifies Causal Links Between Blood Proteins and Acute Pancreatitis. Gastroenterology. 164(6). 953–965.e3. 32 indexed citations
9.
Gagnon, Éloi, Émilie Gobeil, Jérôme Bourgault, et al.. (2022). Mendelian randomization prioritizes abdominal adiposity as an independent causal factor for liver fat accumulation and cardiometabolic diseases. SHILAP Revista de lepidopterología. 2(1). 130–130. 14 indexed citations
10.
Choi, Béatrice S.-Y., Thibault Varin, Patricia L. Mitchell, et al.. (2022). Gnotobiotic mice housing conditions critically influence the phenotype associated with transfer of faecal microbiota in a context of obesity. Gut. 72(5). 896–905. 8 indexed citations
11.
Gobeil, Émilie, Nele Taba, Nooshin Ghodsian, et al.. (2022). Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease. Metabolites. 12(5). 440–440. 25 indexed citations
12.
Perrot, Nicolas, Jérôme Bourgault, Christian Couture, et al.. (2021). A trans‐omic Mendelian randomization study of parental lifespan uncovers novel aging biology and therapeutic candidates for chronic diseases. Aging Cell. 20(11). e13497–e13497. 10 indexed citations
13.
Mitchell, Patricia L., Geneviève Pilon, Philippe St‐Pierre, et al.. (2021). Cholecalciferol Supplementation Does Not Prevent the Development of Metabolic Syndrome or Enhance the Beneficial Effects of Omega-3 Fatty Acids in Obese Mice. Journal of Nutrition. 151(5). 1175–1189. 7 indexed citations
14.
Bourgault, Jérôme, Nicolas Perrot, Patricia L. Mitchell, et al.. (2021). Lipoprotein Proteomics and Aortic Valve Transcriptomics Identify Biological Pathways Linking Lipoprotein(a) Levels to Aortic Stenosis. Metabolites. 11(7). 459–459. 11 indexed citations
15.
Chevrier, Geneviève, Patricia L. Mitchell, Laurie‐Eve Rioux, et al.. (2015). Low-Molecular-Weight Peptides from Salmon Protein Prevent Obesity-Linked Glucose Intolerance, Inflammation, and Dyslipidemia in LDLR−/−/ApoB100/100 Mice. Journal of Nutrition. 145(7). 1415–1422. 49 indexed citations
16.
White, Phillip J., Patricia L. Mitchell, Michael Schwab, et al.. (2015). Transgenic ω-3 PUFA enrichment alters morphology and gene expression profile in adipose tissue of obese mice: Potential role for protectins. Metabolism. 64(6). 666–676. 37 indexed citations
17.
White, Phillip J., Philippe St‐Pierre, Alexandre Charbonneau, et al.. (2014). Protectin DX alleviates insulin resistance by activating a myokine-liver glucoregulatory axis. Nature Medicine. 20(6). 664–669. 97 indexed citations
18.
Mitchell, Patricia L., et al.. (2014). Case Series of 10 Drug-Refractory IBS Patients Who Respond to Oral Serum-Derived Bovine Immunoglobulin/Protein Isolate (SBI). Open Journal of Gastroenterology. 4(10). 321–328. 4 indexed citations
19.
Cooper, Margaret H., Jessica R. Miller, Patricia L. Mitchell, D Currie, & Roger S. McLeod. (2008). Conjugated linoleic acid isomers have no effect on atherosclerosis and adverse effects on lipoprotein and liver lipid metabolism in apoE−/− mice fed a high-cholesterol diet. Atherosclerosis. 200(2). 294–302. 41 indexed citations
20.
Mitchell, Patricia L., et al.. (2005). Effect of conjugated linoleic acid isomers on lipoproteins and atherosclerosis in the Syrian Golden hamster. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1734(3). 269–276. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dennis D. Black Breakdown of academic impact, for papers by Martina Müller‐Nurasyid Breakdown of academic impact, for papers by Ivan Tancevski Breakdown of academic impact, for papers by Edgar Delvin Breakdown of academic impact, for papers by Heather Teague Breakdown of academic impact, for papers by Jean‐Louis Paul Breakdown of academic impact, for papers by Kiyonori Kuriki Breakdown of academic impact, for papers by Hennie M.J. Roelofs Breakdown of academic impact, for papers by Yoshikazu Ohtsuka Breakdown of academic impact, for papers by James P. Nolan
Rankless by CCL
2026